FOLD
Amicus Therapeutics Inc
Price:  
9.57 
USD
Volume:  
2,714,513.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

FOLD WACC - Weighted Average Cost of Capital

The WACC of Amicus Therapeutics Inc (FOLD) is 7.8%.

The Cost of Equity of Amicus Therapeutics Inc (FOLD) is 7.60%.
The Cost of Debt of Amicus Therapeutics Inc (FOLD) is 8.80%.

Range Selected
Cost of equity 6.60% - 8.60% 7.60%
Tax rate 1.00% - 1.50% 1.25%
Cost of debt 7.00% - 10.60% 8.80%
WACC 6.7% - 8.8% 7.8%
WACC

FOLD WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.6 0.67
Additional risk adjustments 0.0% 0.5%
Cost of equity 6.60% 8.60%
Tax rate 1.00% 1.50%
Debt/Equity ratio 0.13 0.13
Cost of debt 7.00% 10.60%
After-tax WACC 6.7% 8.8%
Selected WACC 7.8%